DBV Technologies S.A. (DBVTF)

↓ Download CSV

CIK 0001613780 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated I0
  • Fiscal year ends Dec 31

In fiscal 2025, DBV Technologies S.A. reported revenue of $5.64M, up 35.8% from the prior year. The company ran a net loss, with a net margin of -2607.3%. It held $233.72M in total assets against $64.95M in total liabilities.

Key ratios (FY2025)

-2609.2%
Operating margin
-2607.3%
Net margin
-87.1%
Return on equity
+35.8%
Revenue growth (YoY)
Metric (FY)20252024202320222021202020192018
Revenue$5.64M$4.15M$15.73M$4.84M$5.71M$11.28M$14.71M
Operating Income-$147.06M-$116.59M-$76.43M-$96.63M-$98.61M-$158.84M-$171.02M
Net Income-$146.95M-$113.92M$72.71M$96.27M-$97.81M-$159.56M-$172.01M
EPS (Diluted)$-1.05$-1.17$-0.76$-1.24$-1.78
Total Assets$233.72M$65.66M$182.99M$246.52M$146.72M$272.25M$271.73M
Total Liabilities$64.95M$38.27M$42.80M$52.06M$47.45M$66.75M$78.54M
Shareholders' Equity$168.77M$27.39M$140.19M$194.45M$99.27M$205.49M$193.19M$138.87M
Cash & Equivalents$194.17M$32.46M$141.37M$209.19M$77.30M$196.35M$193.25M$140.57M
Operating Cash Flow-$121.18M-$104.47M-$79.65M-$55.67M-$108.24M-$165.61M-$148.35M
Capital Expenditures$532.0K$2.34M$677.0K$754.0K$910.0K$2.79M$5.57M
Shares Outstanding139.57M97.00M95.12M77.38M54.92M